Director of Go-To-Market and Strategy, Pharma

Director of Go-To-Market and Strategy, Pharma ABOUT US Hippocratic AI is the leading generative AI company in healthcare. We have the only system that can have safe, autonomous, clinical conversations with patients. We have trained our own LLMs as part of our Polaris constellation, resulting in a system with over 99.9% accuracy. WHY JOIN OUR TEAM Reinvent healthcare with AI that puts safety first. We’re building the world’s first healthcare‑only, safety‑focused LLM — a breakthrough platform designed to transform patient outcomes at a global scale. This is category creation. Work with the people shaping the future. Hippocratic AI was co‑founded by CEO Munjal Shah and a team of physicians, hospital leaders, AI pioneers, and researchers from institutions like El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, Meta, Microsoft, and NVIDIA. Backed by the world’s leading healthcare and AI investors. We recently raised a $126M Series C at a $3.5B valuation, led by Avenir Growth, bringing total funding to $404M with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children’s, WellSpan Health, John Doerr, Rick Klausner, and others. Our momentum and investor backing have opened direct relationships with CEOs and C-1 leaders at some of the largest pharma companies in the world. You will step into active, senior-level conversations with top-50 pharma organizations and take ownership of these relationships — building on a foundation of credibility and access that most companies spend years trying to establish. Build alongside the best in healthcare and AI. Join experts who’ve spent their careers improving care, advancing science, and building world‑changing technologies — ensuring our platform is powerful, trusted, and truly transformative. Location Requirement We believe the best ideas happen together. To support fast collaboration and a strong team culture, this role is expected to be in our Palo Alto office five days a week, unless otherwise specified. We are seeking a Director of Go-to-Market and Strategy, Pharma to define Hippocratic AI's strategic positioning in the pharma market and lead the commercial execution that turns that strategy into enterprise revenue. This is a role that lives at the intersection of pharma commercialization strategy and enterprise business development — for someone who can develop the thesis on where AI transforms pharma operations, build the strategic frameworks that make that thesis actionable, and then personally drive the enterprise relationships and deal cycles that convert it into signed contracts. This is a strategy-first commercial role. Before you sell anything, you will define what we sell, to whom, and why it matters — grounding the company's pharma go-to-market in a deep understanding of how therapies are commercialized, how patient services programs are designed and funded, how brand teams allocate investment, and where the pharma commercial model is under the most pressure to evolve. You will shape the strategic narrative that gives Hippocratic AI permission to be in the room with pharma C-suites — and then you will be the person in that room, leading the conversations that open accounts and close deals. The ideal candidate has deep roots in pharma commercialization strategy — someone who has spent their career advising pharma companies on launch excellence, commercial model design, patient engagement, market access, and brand lifecycle management, and who has converted that advisory credibility into large-scale business development outcomes. You understand the commercial lifecycle of a therapy from the pipeline through loss of exclusivity. You know where pharma's strategic priorities are shifting, which organizational functions hold budget and influence, and how enterprise buying decisions actually get made. And you have the relationships and reputation to engage pharma leadership as a strateg ... (truncated, view full listing at source)